Literature DB >> 18359294

Polo-box domains confer target specificity to the Polo-like kinase family.

Barbara C M van de Weerdt1, Dene R Littler, Rob Klompmaker, Angelina Huseinovic, Alex Fish, Anastassis Perrakis, René H Medema.   

Abstract

Polo-like kinases (Plks) contain a conserved Polo-box domain, shown to bind to phosphorylated Ser-pSer/pThr-Pro motifs. The Polo-box domain of Plk-1 mediates substrate interaction and plays an important role in subcellular localization. Intriguingly, the major interactions between the PBD and the optimal recognition peptide are mediated by highly conserved residues in the PBD, suggesting there is little target specificity conveyed by the various PBDs. However, here we show that the affinity of the purified Plk1-3 PBDs to both a physiological Cdc25C derived phospho-peptide and an optimal recognition phospho-peptide differs significantly among family members. To decipher the role of the PBDs and kinase domains in inferring Plk specificity, we exchanged the PBD of Plk1 (PBD1) with the PBD of Plk2, 3, or 4 (PBD2-4). The resulting hybrid proteins can restore bipolar spindle formation and centrosome maturation in Plk1-depleted U2OS cells to various degrees. In these experiments PBD2 was most efficient in complementing PBD-function. Using the MPM2 antibody that recognizes a large set of mitotic phospho-proteins, we could show that PBD1 and PBD2 display some limited overlap in target recognition. Thus, PBDs convey a significant deal of target specificity, indicating that there is only a limited amount of functional redundancy possible within the Plk family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359294     DOI: 10.1016/j.bbamcr.2008.02.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

2.  Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.

Authors:  Wen-Jian Qian; Terrence R Burke
Journal:  Amino Acids       Date:  2013-08-02       Impact factor: 3.520

Review 3.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

4.  Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.

Authors:  Arminja N Kettenbach; Devin K Schweppe; Brendan K Faherty; Dov Pechenick; Alexandre A Pletnev; Scott A Gerber
Journal:  Sci Signal       Date:  2011-06-28       Impact factor: 8.192

Review 5.  Understanding the Polo Kinase machine.

Authors:  V Archambault; G Lépine; D Kachaner
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

Review 6.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

7.  Preparation of orthogonally protected (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptides.

Authors:  Fa Liu; Jung-Eun Park; Kyung S Lee; Terrence R Burke
Journal:  Tetrahedron       Date:  2009-11-21       Impact factor: 2.457

8.  Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.

Authors:  Jeanette Schwarz; Stefanie Schmidt; Olga Will; Tomas Koudelka; Kaja Köhler; Melanie Boss; Björn Rabe; Andreas Tholey; Jürgen Scheller; Dirk Schmidt-Arras; Michael Schwake; Stefan Rose-John; Athena Chalaris
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

9.  Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay.

Authors:  Karine Normandin; Jean-François Lavallée; Marie Futter; Alexandre Beautrait; Jean Duchaine; Sébastien Guiral; Anne Marinier; Vincent Archambault
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

Review 10.  Polo-box domain: a versatile mediator of polo-like kinase function.

Authors:  Jung-Eun Park; Nak-Kyun Soung; Yoshikazu Johmura; Young H Kang; Chenzhong Liao; Kyung H Lee; Chi Hoon Park; Marc C Nicklaus; Kyung S Lee
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.